Your browser is no longer supported. Please, upgrade your browser.
Settings
AGRX Agile Therapeutics, Inc. daily Stock Chart
AGRX [NASD]
Agile Therapeutics, Inc.
Index- P/E- EPS (ttm)-1.01 Insider Own0.70% Shs Outstand28.77M Perf Week36.29%
Market Cap154.49M Forward P/E- EPS next Y-0.77 Insider Trans45.88% Shs Float28.57M Perf Month37.34%
Income-28.90M PEG- EPS next Q-0.28 Inst Own93.10% Short Float4.61% Perf Quarter76.07%
Sales- P/S- EPS this Y26.20% Inst Trans-0.01% Short Ratio7.95 Perf Half Y126.58%
Book/sh1.24 P/B4.33 EPS next Y30.00% ROA-44.30% Target Price10.75 Perf Year-21.03%
Cash/sh1.45 P/C3.70 EPS next 5Y- ROE-65.00% 52W Range1.82 - 8.15 Perf YTD-5.79%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-34.11% Beta-
Dividend %- Quick Ratio3.80 Sales past 5Y- Gross Margin- 52W Low195.05% ATR0.27
Employees19 Current Ratio3.80 Sales Q/Q- Oper. Margin- RSI (14)88.62 Volatility9.23% 5.68%
OptionableNo Debt/Eq0.43 EPS Q/Q4.20% Profit Margin- Rel Volume2.44 Prev Close4.93
ShortableYes LT Debt/Eq0.26 EarningsAug 07 AMC Payout- Avg Volume165.72K Price5.37
Recom1.50 SMA2037.25% SMA5044.46% SMA20024.47% Volume404,974 Change8.92%
Jul-19-17Initiated H.C. Wainwright Buy $10
Jan-08-16Initiated Cantor Fitzgerald Buy
Apr-02-15Initiated FBR Capital Outperform $17
Jun-17-14Initiated William Blair Outperform
Jun-17-14Initiated RBC Capital Mkts Outperform $12
Jun-28-17 06:00PM  AGRX: NDA for Twirla® Filed with FDA; Six Month Review Time Expected Zacks Small Cap Research
Jun-27-17 08:00AM  Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Contraceptive Patch, Twirla® GlobeNewswire
May-15-17 12:00PM  AGRX: Initiating Coverage of Agile Therapeutics; NDA for Weekly Contraceptive Patch Set to Be Filed Zacks Small Cap Research
May-08-17 05:27PM  Agile Therapeutics reports 1Q loss Associated Press
04:11PM  Agile Therapeutics Reports First Quarter 2017 Financial Results GlobeNewswire
May-06-17 02:05PM  Agile Therapeutics Reports Additional Phase 3 SECURE Study Results Relating to Twirla® at ACOG 2017 GlobeNewswire
May-03-17 04:15PM  Agile Therapeutics to Present Additional Phase 3 Data at the 2017 Annual Clinical and Scientific Meeting of the American Congress of Obstetricians and Gynecologists GlobeNewswire
Apr-27-17 07:30AM  Agile Therapeutics Announces Presentation of SECURE Phase 3 Data at the 2017 Congress on Womens Health GlobeNewswire
Apr-11-17 07:00AM  Agile Therapeutics Announces Results of its Pre-Submission Meeting with FDA GlobeNewswire +5.07%
Mar-21-17 01:04PM  AGILE THERAPEUTICS INC Financials
Mar-17-17 08:15AM  Agile Therapeutics (AGRX) Catches Eye: Stock Moves Up 14% Zacks +9.29%
Mar-16-17 04:39PM  AGILE THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits +13.98%
Mar-15-17 04:42PM  AGILE THERAPEUTICS INC Files SEC form 10-K, Annual Report +5.83%
Mar-08-17 05:14PM  Agile Therapeutics reports 4Q loss Associated Press +5.39%
04:26PM  AGILE THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex
04:15PM  Agile Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results GlobeNewswire
Mar-06-17 11:03AM  IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces a Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
10:10AM  DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Agile Therapeutics, Inc. (AGRX) & Lead Plaintiff Deadline - March 7, 2017 GlobeNewswire
Mar-03-17 08:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Agile Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline AGRX GlobeNewswire
09:32AM  UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Shareholders of Agile Therapeutics, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 7, 2017 Business Wire
Mar-02-17 06:07PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Agile Therapeutics, Inc. - AGRX PR Newswire
Mar-01-17 04:10PM  Agile Therapeutics to Present at 29th Annual ROTH Conference GlobeNewswire
10:24AM  DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Agile Therapeutics, Inc. (AGRX) and Lead Plaintiff Deadline - March 7, 2017 Accesswire
Feb-27-17 03:38PM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces a Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
02:21PM  DEADLINE ALERT: Brower Piven Reminds Investors Of The March 7, 2017 Deadline In Class Action Lawsuit And Encourages Investors With Losses In Excess of $100,000 From Investment In Agile Therapeutics, Inc. To Contact The Firm Business Wire
11:08AM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
10:05AM  AGRX INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Agile Therapeutics, Inc. and a Lead Plaintiff Deadline of March 7, 2017 Business Wire
Feb-26-17 02:21PM  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $50,000 Investing in Agile Therapeutics, Inc. to Contact the Firm Before Imminent Lead Plaintiff Deadline Accesswire
Feb-24-17 10:32AM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces a Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
10:30AM  Investor Alert: GPM Reminds Investors of the March 7 Deadline in the Class Action Lawsuit Against Agile Therapeutics, Inc. Business Wire
Feb-23-17 11:41PM  Pawar Law Group Announces that a Securities Class Action Lawsuit has been filed Against Agile Therapeutics, Inc. - AGRX Accesswire
Feb-22-17 01:48PM  SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
11:35AM  AGRX SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Agile Therapeutics, Inc. and a Lead Plaintiff Deadline of March 7, 2017 PR Newswire
10:17AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Agile Therapeutics, Inc. (AGRX) and Lead Plaintiff Deadline - March 7, 2017 Accesswire
Feb-21-17 11:47AM  IMPORTANT INVESTOR NOTICE: Khang & Khang LLP Announces a Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
11:20AM  Lawsuit for Investors in NASDAQ: AGRX Shares against Agile Therapeutics Inc. Announced by Shareholders Foundation Accesswire
Feb-17-17 08:37PM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
08:30PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Agile Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - AGRX Accesswire
11:29AM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces a Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
09:43AM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Agile Therapeutics, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 7, 2017 AGRX Business Wire
Feb-15-17 06:39PM  SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire +6.84%
02:30PM  AGRX NOTICE: Rosen Law Firm Reminds Agile Therapeutics Investors of Important Class Action Deadline AGRX GlobeNewswire
11:32AM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces a Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
10:16AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Agile Therapeutics, Inc. (AGRX) and Lead Plaintiff Deadline: March 7, 2017 Accesswire
Feb-14-17 04:00PM  Agile Therapeutics to Present at the RBC Capital Markets 2017 Global Healthcare Conference GlobeNewswire
Feb-13-17 02:55PM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
02:43PM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces a Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
01:28PM  AGRX INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Agile Therapeutics, Inc. and a Lead Plaintiff Deadline of March 7, 2017 Business Wire
Feb-10-17 08:10PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Agile Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - AGRX Accesswire
12:11PM  SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
10:02AM  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $50,000 Investing In Agile Therapeutics, Inc. To Contact The Firm Before Lead Plaintiff Deadline PR Newswire
Feb-09-17 11:00AM  IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces a Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
10:30AM  March 7 Deadline Alert: Law Offices of Howard G. Smith Reminds Agile Therapeutics, Inc. Investors of Upcoming Lead Plaintiff Deadline and Encourages Investors to Contact the Firm Business Wire
Feb-08-17 04:29PM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
01:27PM  AGRX SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Agile Therapeutics, Inc. and a Lead Plaintiff Deadline of March 7, 2017 GlobeNewswire
Feb-07-17 10:58AM  INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
10:04AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Agile Therapeutics, Inc. (AGRX) and Lead Plaintiff Deadline: March 7, 2017 Accesswire
Feb-03-17 08:45PM  SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire +5.43%
06:36PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Agile Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline AGRX GlobeNewswire
02:41PM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces a Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
01:02PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Agile Therapeutics, Inc. (AGRX) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit GlobeNewswire
11:37AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Agile Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 7, 2017 AGRX GlobeNewswire
Feb-02-17 04:15PM  Agile Therapeutics to Present at the 2017 BIO CEO & Investor Conference GlobeNewswire
11:31AM  IMPORTANT AGRX SHAREHOLDER DEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
10:09AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Agile Therapeutics, Inc. (AGRX) and Lead Plaintiff Deadline: March 7, 2017 Accesswire
Jan-30-17 11:25AM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Business Wire
10:38AM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Agile Therapeutics, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 7, 2017 - AGRX Accesswire
09:40AM  Lawsuit for Investors in Agile Therapeutics Inc (NASDAQ:AGRX) shares announced by Shareholders Foundation GlobeNewswire
Jan-27-17 11:05PM  IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces a Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
07:45PM  RM LAW Announces Class Action Lawsuit Against Agile Therapeutics, Inc. PR Newswire
03:27PM  IMPORTANT AGRX INVESTOR DEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
02:52PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Agile Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - AGRX PR Newswire
Jan-26-17 03:46PM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces a Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
12:16PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Agile Therapeutics, Inc. AGRX GlobeNewswire
10:57AM  CRUCIAL INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
10:10AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Agile Therapeutics, Inc. (AGRX) and Lead Plaintiff Deadline: March 7, 2017 GlobeNewswire
Jan-25-17 06:56PM  IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces a Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire +7.11%
06:00PM  WOLF HALDENSTEIN AGILE THERAPEUTICS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed on behalf of shareholders of Agile Therapeutics, Inc. in the Distric GlobeNewswire
11:37AM  Levi & Korsinsky Notifies Shareholders of a Complaint Filed in U.S. District Court to Recover Losses Suffered by Investors in Agile Therapeutics, Inc. (AGRX)
Jan-20-17 09:08PM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces a Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
08:10PM  SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Agile Therapeutics, Inc. and Certain Officers AGRX GlobeNewswire
05:21PM  CRUCIAL SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
02:19PM  INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Agile Therapeutics, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit Business Wire
Jan-19-17 04:15PM  Agile Therapeutics to Present at Noble Capital Markets Thirteenth Annual Investor/Equity Conference GlobeNewswire
Jan-18-17 05:03PM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces a Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
02:30PM  AGILE THERAPEUTICS LOSS NOTICE: Rosen Law Firm Reminds Investors of Important Class Action Deadline AGRX Business Wire
11:42AM  Lifshitz & Miller Law Firm Announces Investigation of Abeona Therapeutics Inc., Agile Therapeutics, Inc., Alere Inc., Floteck Industries, Inc., Insys Therapeutics Inc., MTS Systems Corporation, Ophthotech Corporation and Teekay Corporation PR Newswire
Jan-17-17 12:11PM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces a Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
11:36AM  AGRX INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Agile Therapeutics, Inc. and a Lead Plaintiff Deadline of March 7, 2017 GlobeNewswire
06:55AM  IMPORTANT EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
04:00AM  IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
Jan-16-17 10:16AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Agile Therapeutics, Inc. (AGRX) and Lead Plaintiff Deadline: March 7, 2017 Accesswire
Jan-14-17 01:53PM  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
Jan-13-17 05:24PM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Business Wire
04:14PM  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $50,000 Investing In Agile Therapeutics, Inc. To Contact The Firm Before Lead Plaintiff Deadline GlobeNewswire
Jan-12-17 08:29PM  IMPORTANT SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
08:00PM  SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Agile Therapeutics, Inc. (AGRX) To Contact Brower Piven Before The Lead Plaintiff Deadl GlobeNewswire
Jan-11-17 04:29PM  Robbins Arroyo LLP: Agile Therapeutics, Inc. (AGRX) Misled Shareholders According to a Recently Filed Class Action Business Wire
01:37PM  SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
10:10AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Agile Therapeutics, Inc. (AGRX) and Lead Plaintiff Deadline: March 7, 2017 GlobeNewswire
Agile Therapeutics, Inc., a forward-thinking women's healthcare company, focuses on the development and commercialization of prescription contraceptive products for women. Its lead product candidate is Twirla, also known as AG200-15, a once-weekly contraceptive patch, which completed Phase III clinical trials. The company is also developing a pipeline of other new transdermal contraceptive products, including AG200-ER, a regimen that allows a woman to extend the length of her cycle; AG200-SP, which is a regimen designed to provide shorter lighter periods; and AG890, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was founded in 1997 and is headquartered in Princeton, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shetty AjitDirectorJun 12Option Exercise3.757,00026,2507,000Jun 14 04:30 PM
Selman ReneeChief Commercial OfficerMay 11Buy3.6853,333196,26553,333May 12 07:59 AM
ALTOMARI ALFREDChairman and Chief Executive OMay 11Buy3.5110,00035,100151,587May 12 07:50 AM
ALTOMARI ALFREDChairman & Chief Exec OfficerApr 11Option Exercise1.7630,00052,800141,587Apr 12 04:32 PM